Loading…
NEPH
Nephros Inc
NASDAQ· Healthcare· Medical Instruments & Supplies· CUSIP 640671400
$4.55+5.57%Price as of Aug 29, 18:41 UTC · updated once a day, after the close
Key metrics
- Market cap
- $49.41M
- P/E
- 28.4x
- Forward P/E
- 21.7x
- P/B
- 4.1x
- Dividend yield
- —
- Payout
- —
- EPS
- $0.16
- ROE
- 16.10%
- Profit margin
- 8.38%
- Revenue growth
- +36.20%
- Beta
- 1.52
- 52-week high
- $6.42
- 52-week low
- $2.66
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -46.0% over 5Y.
today you would have $482.33▼ -51.8%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 17 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $4.88 | $1.47 | $3.46 | $1.16 | $5.90 | $8.58 | $9.95 | $5.13 | $4.05 | $3.33 | $1.98 | $7.11 | $3.78 | $10.71 | $6.21 | $18.00 | $140.40 | |
Fair price, seven ways
Seven formulas applied to what the company reported. None of them predicts a price — each answers what the stock would be worth if its assumption held. The assumption is printed next to every number, because it is the assumption that produces the result.
Earnings
$1.99
Square root of 22.5 × earnings × book value — the two ceilings Graham proposed. Blind to intangibles, so it undervalues software and brands.
Earnings
$4.00
Earnings growing 25.0% a year plus a 0.0% dividend — Lynch adds the yield to the growth rate, so a payer is not priced like a company that returns nothing. Growth capped at 25%.
Earnings
$3.59
Median P/E of 22.4 among peers in the sector.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Cash flow
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Operating
$2.11
Sector median of 13.3x operating profit, less net debt. Sees the business before its financing, so debt does not distort the comparison. Banks have no EBITDA — interest is their revenue, not a cost.
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| MREOMereo BioPharma Group plc | $0.32 | — | 1.8x | — | -67.85% | $50.51M |
| MDAISpectral AI, Inc. | $1.57 | — | — | — | — | $50.53M |
| GNTAGenenta Science S.p.A. | $1.00 | — | 0.9x | — | -38.03% | $48.22M |
| POCIPrecision Optics Corporation Inc | $4.40 |
About the company
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
- 36
- South Orange, United States
Company description provided by Yahoo Finance.